Germany· DE-A57-8a1ae5d5c133101a
Berinert
A medicinal product containing c1 esterase inhibitor (human), registered in Germany by Csl Behring Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- C1 Esterase Inhibitor (Human)
- Manufacturer
- Csl Behring Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
C1 esterase inhibitor (human) in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBERINERTCSL Behring GmbH, Marburg
- United KingdomBerinert 1,500unit powder and solvent for solution for injection vialsCSL Behring UK Ltd
- BelgiumBerinert 2000 IUCSL Behring
- IrelandBerinert 1500 IU Powder and solvent for solution for injectionCSL Behring GmbH
- IcelandBerinertCSL Behring GmbH*
- NorwayBerinertCSL Behring GmbH (2)
- SwedenBerinert 1500 IE Pulver och vätska till injektionsvätska, lösningCSL Behring GmbH
- CanadaBERINERT 1500CSL BEHRING CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Berinert
- Belgium · Berinert
- Bulgaria · Беринерт
- Cyprus · Berinert
- Czechia · Berinert
- Denmark · Berinert
- Estonia · Berinert Iv, Berinert Sc
- Spain · Berinert
- Finland · Berinert
- France · Berinert
- United Kingdom (Northern Ireland) · Berinert
- Greece · Berinert
- Croatia · Berinert
- Hungary · Berinert
- Ireland · Berinert
- Iceland · Berinert, Cinryze
- Italy · Berinert
- Liechtenstein · Cinryze
- Lithuania · Human C1-Esterase Inhibitor Csl Behring
- Luxembourg · Berinert
- Malta · Berinert
- Netherlands · Berinert
- Norway · Berinert, Cinryze
- Poland · Berinert
- Portugal · Berinert
- Romania · Berinert
- Sweden · Berinert
- Slovenia · Berinert
- Slovakia · Berinert
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/56de1fdb-d15c-4b28-a3f5-115318844e0a GET /v1/drugs/56de1fdb-d15c-4b28-a3f5-115318844e0a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Subcutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "C1 Esterase Inhibitor (Human)",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about c1 esterase inhibitor (human).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.